Some new research on the Ebola virus in fruit bats has found that Ebola virus antibodies are presented in a small proportion of bats in Bangladesh. This indicates the global reach of Ebola-like diseases.
A Canadian science team have undertaken research to show that the a virulent form of the Ebola virus could mutate into an airborne pathogen. Such a mutation would also be capable of species to species transmission.
Scientists operating at the Massachusetts Institute of Technology have developed an antiviral drug that promises to end infections from virtually all known viruses, from the common cold to exotic hemorrhagic fevers.